Evidence map›Paper›PMID 36517497›Full record

ArticleScientific reports2022

Characterization of Boeremia exigua causing stem necrotic lesions on Luobuma in northwest China.

Yanru Lan, Tingyu Duan

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Luobuma Leaf Spot Disease Caused byJournal of fungi (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Yanru LanState Key Laboratory of Herbage Improvement and Grassland Agro-Ecosystems, Lanzhou University, Lanzhou, 730020, China.
Tingyu DuanState Key Laboratory of Herbage Improvement and Grassland Agro-Ecosystems, Lanzhou University, Lanzhou, 730020, China. duanty@lzu.edu.cn.
Lanzhou University · CNMinistry of Agriculture and Rural Affairs · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Luobuma (Apocynum venetum, Poacynum pictum, and P. hendersonni) are perennial herbs widely used in the textile and medical industries and ecological restoration. In the summer of 2020, reddish-brown or off-white sunken shape necrotic lesions were observed on the stems and shoots of seven Luobuma ecotypes grown in the field in Yuzhong County, Gansu province of China, which is a limiting factor that affects the growth, function and application of Luobuma. To make clear whether the new symptoms were caused by a novel pathogen, a combined research in field and greenhouse was conducted. Based on the morphological and molecular analysis results, the pathogen causing the necrotic lesions was identified as Boeremia exigua var. rhapontica. The incidence and disease index of the seven ecotypes in the field ranged from 11.49 to 33.68% and 6.63 to 23.01, respectively, from 2020 to 2021. The results showed that the disease severity gradually increased with the growing season. According to the pathogenicity analysis of the eight ecotypes in the greenhouse, the ecotypes Pp-BMK and Pp-BMH were susceptible, while ecotype Pp-BMQ was resistant to Boeremia exigua var. rhapontica infection. Thus, the present study provides a theoretical basis for preventing and controlling the stem and leaf necrotic lesions disease on Luobuma by planting resistant varieties/ecotypes. To our knowledge, this is the first report of stem necrotic lesions and leaf spots on Luobuma caused by B. exigua var. rhapontica.

Indexed as

ApocynumAscomycotaChinaEcotype

Identifiers

PMID36517497
PMCPMC9751102
OpenAlexW4311477073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.